The senior management of DPPC will participate in the international exhibition CPHI India, recognized as one of Asia’s most significant gatherings for the pharmaceutical industry and a valuable platform for expanding regional and global collaborations.
DPPC’s presence at this exhibition aims to strengthen engagement with leading companies in the fields of Active Pharmaceutical Ingredients (API), Intermediates, and industrial machinery*. The focus of these discussions will be on identifying new pathways for technology transfer, enhancing the supply chain, and establishing sustainable frameworks for bilateral cooperation.
This participation also provides an opportunity to showcase DPPC’s production and technological capabilities and to highlight the company’s role in advancing the country’s API manufacturing sector. As an influential player in Iran’s pharmaceutical supply chain with a substantial share in API production and long-standing partnerships with domestic and international pharmaceutical companies, DPPC plays a key role in strengthening the quality, resilience, and security of Iran’s pharmaceutical system. India, as one of the world’s largest hubs for pharmaceutical raw materials and industrial equipment, has long held a significant position in fostering industrial cooperation between the two countries. DPPC’s active participation in CPHI India is expected to serve as an effective step toward deepening these collaborations and creating new opportunities for the development of the nation’s pharmaceutical value chain
